Search
for
Sort by
Research 31–60 of 1000+
- Cronkhite-Canada Syndrome Associated With Superficial Esophageal Carcinoma: A Case Report and Literature Review
- Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports
- What's new in the pathogeneses and triggering factors of bullous pemphigoid
- Thrombophilia and Polycythemia in a Woman With Budd-Chiari Syndrome
- Znaczenie chorób pęcherzycowych w diagnostyce różnicowej estetycznych problemów twarzy
- Cronkhite–Canada Syndrome With Multiple Mesenteric Lymphadenopathy: A Case Report
- Cronkhite-Canada Syndrome (CCS)—A Rare Case Report
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- Cronkhite-Canada Syndrome: A Case Report and Literature Review of Gastrointestinal Polyposis Syndrome
- Th22 is the effector cell of thymosin β15-induced hair regeneration in mice
- Cronkhite-Canada syndrome: A case report and literature review
- Cases Report the Cronkhite-Canada Syndrome
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity
- Targeting integrin pathways: mechanisms and advances in therapy
- Thymic Stromal Lymphopoietin in Cutaneous Immune-Mediated Diseases
- Catalytic Antibodies in Norm and Systemic Lupus Erythematosus
- A Case Report of Cronkhite-Canada Syndrome Complicated by Membranous Nephropathy
- Immune therapies for alopecia areata: evidence and new perspectives
- Proteomic Profiling of Central Centrifugal Cicatricial Alopecia Reveals Role of Humoral Immune Response Pathway and Metabolic Dysregulation
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- New Modalities in the Treatment of Refractory Alopecia Areata
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- New insights into the phenomenon of remissions and relapses in autoimmune diseases and the puzzle of benign autoantibodies in healthy individuals